Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and…

Overview of attention for article published in Biologics: Targets & Therapy, January 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis

Article in European Journal of Clinical Pharmacology (December 2023)

Efficacy and Safety of Adalimumab in Pediatric Patients With Crohn’s Disease: A Systematic Review and Meta- analysis

Preprint in Research Square (April 2023)

Efficacy and safety of Adalimumab in treating pediatric Crohn′s disease

Article in Testowy IndexCopernicus (September 2022)